A study using hepatic arterial infusion to deliver treatment to colorectal cancer patients with liver metastases is unlikely to lead to wholesale changes in clinical practice, but may spur new studies into the role of local delivery of triple combination chemotherapy in these patients.
Related Articles
Focus
Chemobrain: delving into possible mechanisms
Senza categoria
N E W S R O U N D
Featured
Leave a Reply